Advertisement

Practice Management

Advertisement

The FDA recently held a two-day public hearing, titled "Draft Guidances Relating to the Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products." At this hearing, the federal agency heard comments and feedback regarding its new draft guidelines on…

Advertisement